Articles

11. Brochure: Finished Dosage Forms 2/21/2012
    DSM is a global provider of finished dosage form manufacturing and related services to pharmaceutical and biopharmaceutical markets.
12. Pharma Beyond Borders: India As An Outsourcing Destination 2/1/2012
    The only thing that is constant in life (and that goes for the global pharma industry too!) is change. The need to access emerging markets with new and cost effective drugs, the diminishing blockbuster product model, and the far more complicated life cycle management programs are just some of the new and ever changing challenges that innovator pharmaceutical companies face in today’s environment. By Manoj Mehrotra
13. Brochure: Biologics Contract Manufacturing & Technology Solutions 1/30/2012

    DSM provides turn-key biologic manufacturing solutions, contract manufacturing for preclinical development, clinical trials or commercial supply and reduced cost, risk, and time to market.

14. Brochure: Pharma Sterile Dosage Forms 1/30/2012

    DSM offers pharmaceutical and biopharmaceutical customers a lyophilization system with unique benefits. It has the precision to serve increasingly demanding lyophilization cycles, a critical requirement for successful product launches and high commercial yields. 

15. Combination Products 2.0: Applying The New FDA Regulations 1/20/2012
    Combination products, those that contain medical devices embedded with pharmaceutical or biologic components, have become a large and growing segment of the medical device market. Some analysts estimate they represent over 30% of all new product submissions to the FDA. By Steven Richter, Ph.D
16. Veteran Guidance On The CMO Selection Process From James Bruno 11/11/2011

    Life Science Leader magazine put together an executive roundtable article on the CMO selection process for a 2011 special supplement. The intent – to gain a better understanding of the some of the challenges faced during the partnering and provide insights on how to overcome. I received some great responses from James Bruno managing director, Chemical and Pharmaceutical Solutions and Chemical Consultants. By Rob Wright

17. Alkermes Contract Pharma Services 9/28/2011

    With Alkermes Contract Pharma Services, you have the opportunity to outsource your development, scale-up and manufacturing requirements to a trusted, experienced and dedicated expert in outsourcing services.

18. Five Year Trouble Free Manufacturing For Large Pharma Company 9/28/2011

    Alkermes, through the merger with Elan Drug Technologies, to become Alkermes plc, has been developing and manufacturing commercial scale solid oral dosage products for over 40 years.

19. Product & Process Transfer Of Low Solubility Compound With 6 Year OTIF>95% 9/28/2011

    Alkermes, through the merger with Elan Drug Technologies, to form Alkermes plc, has been developing and manufacturing commercial scale solid oral dosage products for over 40 years. This case study demonstrates the successful transfer of a low solubility compound into one of our manufacturing sites and achieving as a result, an OTIF (On-Time-In-Full) consistently over 95%.

20. White Paper: Clinical Trial Material Production And Testing: What Your CMO Is Not Telling You 6/7/2011
    Manufacturing clinical trial material (CTM), and the costs for the associated fill/finish and release work, most likely are not the costliest portions of the pharmaceutical process chain. By Alexander Mello, Director, Project Management